Key result
Oral 10^5 FFU Arg HRV challenge reliably induces diarrhea and virus shedding in 100% of pigs.
Why the study?
Licensed rotavirus vaccines are less efficacious against newly emerging P[6] strains, creating an urgent need for preclinical models to evaluate cross-protective vaccines.
A new gnotobiotic pig model for P[6] human rotavirus was developed, establishing an optimal challenge dose of 10^5 FFU for future vaccine efficacy testing.
Enables standardized P[6] HRV vaccine testing in pigs; leaves open human translation.
Human rotavirus (HRV) is a leading cause of gastroenteritis in children under 5 years of age. Licensed vaccines containing G1P[8] and G1-4P[8] strains are less efficacious against newly emerging P[6] strains, indicating an urgent need for better cross protective vaccines. Here, we report our development of a new gnotobiotic (Gn) pig model of P[6] HRV infection and disease as a tool for evaluating potential vaccine candidates. The Arg HRV (G4P[6]) strain was derived from a diarrheic human infant stool sample and determined to be free of other viruses by metagenomic sequencing. Neonatal Gn pigs were orally inoculated with the stool suspension containing 5.6 × 105 fluorescent focus units (FFU) of the virus. Small and large intestinal contents were collected at post inoculation day 2 or 3. The virus was passaged 6 times in neonatal Gn pigs to generate a large inoculum pool. Next, 33–34 day old Gn pigs were orally inoculated with 10−2, 103, 104, and 105 FFU of Arg HRV to determine the optimal challenge dose. All pigs developed clinical signs of infection, regardless of the inoculum dose. The optimal challenge dose was determined to be 105 FFU. This new Gn pig model is ready to be used to assess the protective efficacy of candidate monovalent and multivalent vaccines against P[6] HRV.
No takes yet. Share an insight, caveat, or question.
Nyblade et al. (2022) studied Human rotavirus infection (n=36). Arg HRV (G4P[6]) vs. Lower doses (10^-2, 10^3, 10^4 FFU) was evaluated on Incidence of diarrhea and virus shedding. Oral inoculation of gnotobiotic pigs with 10^5 FFU of Arg HRV (G4P[6]) was established as the optimal challenge dose, reliably inducing diarrhea and virus shedding in 100% of animals.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: